HER2 | P53 | Ki67 | ||||
---|---|---|---|---|---|---|
Positive/total (percentage) | P | Positive/total (percentage) | P | Positive/total (percentage) | P | |
Total | 9/73 (12.3) | 16/73 (21.9) | 26/73 (35.6) | |||
Tumour size (cm) | ||||||
<2.0 | 4/20 (20.0) | 0.41 | 5/20 (25.0) | 0.94 | 7/20 (35.0) | >0.99 |
≥2.0 | 5/53 (9.4) | 11/53 (20.8) | 19/53 (35.8) | |||
Number of positive lymph nodes | ||||||
0 | 1/22 (4.5) | 0.34 | 3/22 (12.6) | 0.41 | 6/22 (27.2) | 0.47 |
≥1 | 8/51 (15.7) | 13/51 (25.5) | 20/51 (39.2) | |||
Histological grade | ||||||
1 | 0/12 (0) | 0.36 | 0/12 (0) | 0.05 | 3/12 (25.0) | 0.18 |
2 | 6/42 (14.3) | 9/42 (21.4) | 13/42 (31.0) | |||
3 | 3/19 (15.8) | 7/19 (36.8) | 10/19 (52.6) | |||
Estrogen receptor-α | ||||||
Negative | 4/17 (23.5) | 0.23 | 5/17 (29.4) | 0.60 | 8/17 (47.1) | 0.40 |
Positive | 5/56 (8.9) | 11/56 (19.6) | 18/56 (32.1) | |||
Progesterone receptor | ||||||
Negative | 3/18 (16.7) | 0.81 | 5/18 (27.8) | 0.71 | 9/18 (50.0) | 0.23 |
Positive | 6/55 (10.9) | 11/55 (20.0) | 17/55 (30.9) |